Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Uniqure Ord Shs
(NQ:
QURE
)
4.820
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
4.820
Bid (Size)
4.610 (32)
Ask (Size)
5.190 (11)
Prev. Close
4.820
Today's Range
4.820 - 4.820
52wk Range
4.610 - 22.48
Shares Outstanding
47,838,275
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
March 04, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
Performance
YTD
-30.45%
-30.45%
1 Month
-9.91%
-9.91%
3 Month
-15.44%
-15.44%
6 Month
-19.67%
-19.67%
1 Year
-75.56%
-75.56%
More News
Read More
Recap: uniQure Q4 Earnings
February 28, 2024
Via
Benzinga
Why Shares of uniQure Are Up Thursday
October 05, 2023
Via
The Motley Fool
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
February 28, 2024
From
uniQure Inc.
Via
GlobeNewswire
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Via
Benzinga
Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
December 19, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of uniQure Are Dropping Tuesday
September 05, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
December 19, 2023
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 08, 2023
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
November 29, 2023
From
uniQure Inc.
Via
GlobeNewswire
3 Micro-Cap Stocks That Could Be Moonshots
November 14, 2023
Via
InvestorPlace
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 07, 2023
From
uniQure Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 02, 2023
Via
InvestorPlace
uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting
October 24, 2023
From
uniQure Inc.
Via
GlobeNewswire
Gene Therapy Player UniQure To Lay Off 20% Of Workforce, Stop Parkinson's Study
October 05, 2023
Via
Benzinga
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs
October 05, 2023
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2023
From
uniQure Inc.
Via
GlobeNewswire
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
September 15, 2023
Via
Investor's Business Daily
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
Via
Benzinga
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy
September 05, 2023
From
uniQure Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
Via
Benzinga
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 05, 2023
Via
Benzinga
3 Tantalizing Stocks to Buy for Under $10
August 26, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
